AcelRx Hosting Key Opinion Leader Webinar on Niyad™ Nafamostat Program
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Vascular Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Key Opinion Leaders participating will be Stuart Goldstein, MD, Cincinnati Children’s Hospital and Lakhmir Chawla, MD, former Chief of the Division of...
Patients with advanced chronic kidney disease who have hyper- or hypokalemia are at higher risk for ER visits and hospitalization, especially those with high potassium levels.
Vadadustat is the second agent from the HIF-PHI class to fail to receive FDA marketing approval because of safety. A third agent from the class, daprodustat, has not yet undergone FDA review.
Dynamic Infusion Therapy, which is backed by RiverGlade Capital, has acquired Austin-based Vascular Access Consultants, a provider of expert services to healthcare facilities.